1
Nov 14 (Reuters) – Eli Lilly & Co on Saturday released some new data from several clinical trials of its obesity drugs for the ObesityWeek 2026 medical conference, but it has not yet released the full
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)